Medical
ForSight raised $125 million in a Series B round to develop its eye-surgery robot. Backers include Eclipse, Intuitive Surgical co-founder Fred Moll and Adani Group.
A dated step forward on the record · Company-reported
What the source says
“completed a $125 million Series B funding round to support its ophthalmic robotic surgery tech.”
What it means
JASPER (formerly Oryom), from ForSight Robotics, is at stage 3 of 5 on our ladder: pilot. Its stage is set by other milestones on its record; this one adds to the history. This line rests on the company's own announcement; no regulator, customer or independent report confirms it in our sources yet.
Human help: Our sources report it working without human help.
More on JASPER (formerly Oryom)
- ForSight said 26 patients had now had cataract surgery with JASPER in its first human study.
- ForSight said surgeons did the first cataract operation on a human patient with the robot, now renamed JASPER. The study's lead doctor is at the Asian Eye Institute in Manila, Philippines.
- The robot, first called Oryom, was renamed JASPER (Joint Aligned System for Precise Eye Robotics).
- Israel-based ForSight Robotics raised $10 million in a seed round led by Eclipse Ventures and Mithril Capital.